Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD

Respiratory Medicine

Volumn 102, Issue 10, 2008, Pages 1425-1430

  Cazzola, Mario ^a   Biscione, Gian Luca ^b   Pasqua, Franco ^b   Crigna, Girolmina ^b   Appodia, Massimiliano ^a   Cardaci, Vittorio ^c   Ferri, Luigi ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c University of Study of Roma San Raffaele   (Italy)

Author keywords

12 MWT; 6 MWT; COPD; Formoterol

Indexed keywords

FORMOTEROL; SALBUTAMOL;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; INSPIRATORY CAPACITY; LUNG FUNCTION; MALE; OXYGEN TENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WALKING;

AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; ETHANOLAMINES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INSPIRATORY CAPACITY; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; WALKING;

EID: 50349091785     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.04.017     Document Type: Article

References (27)

1. Palange P., Ward S.A., Carlsen K.H., et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 29 (2007) 185-209
2. Pepin V., Saey D., Whittom F., LeBlanc P., and Maltais F. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172 (2005) 1517-1522
3. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
4. Gerardi D.A., Lovett L., Benoit-Connors M.L., Reardon J.Z., and ZuWallack R.L. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J 9 (1996) 431-435
5. Garcia-Aymerich J., Farrero E., Felez M.A., Izquierdo J., Marrades R.M., and Anto J.M. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58 (2003) 100-105
6. Paggiaro P.L., Dahle R., Bakran I., Frith L., Hollingworth K., and Efthimiou J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Lancet 351 (1998) 773-780
7. Pepin V., Brodeur J., Lacasse Y., et al. Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax 62 (2007) 291-298
8. Liesker J.J., Wijkstra P.J., Ten Hacken N.H., Koeter G.H., Postma D.S., and Kerstjens H.A. A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. Chest 121 (2002) 597-608
9. Butland R.J., Pang J., Gross E.R., Woodcock A.A., and Geddes D.M. Two-, six-, and 12-minute walking tests in respiratory disease. BMJ (Clin Res Ed) 284 (1982) 1607-1608
10. Bernstein M.L., Despars J.A., Singh N.P., Avalos K., Stansbury D.W., and Light R.W. Reanalysis of the 12-minute walk in patients with chronic obstructive pulmonary disease. Chest 105 (1994) 163-167
11. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14 (1982) 377-381
12. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
13. Guyatt G.H., Pugsley S.O., Sullivan M.J., et al. Effect of encouragement on walking test performance. Thorax 39 (1984) 818-822
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136 (1987) 225-244
15. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
16. Redelmeier D.A., Bayoumi A.M., Goldstein R.S., and Guyatt G.H. Interpreting small differences in functional status: the six-minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 155 (1997) 1278-1282
17. Troosters T., Gosselink R., and Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 109 (2000) 207-212
18. Cazzola M., MacNee W., Martinez F.J., et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008)
19. Morgan M.D., and Singh S.J. Assessing the exercise response to a bronchodilator in COPD: time to get off your bike?. Thorax 62 (2007) 281-283
20. Neder J.A., Fuld J.P., Overend T., et al. Effects of formoterol on exercise tolerance in severely disabled patients with COPD. Respir Med 101 (2007) 2056-2064
21. O'Donnell D.E., and Webb K.A. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis 148 (1993) 1351-1357
22. Boni E., Corda L., Franchini D., et al. Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. Thorax 57 (2002) 528-532
23. O'Donnell D.E., Voduc N., Fitzpatrick M., and Webb K.A. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 24 (2004) 86-94
24. O'Donnell D.E., Lam M., and Webb K.A. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 542-549
25. Eastwood P.R., Hillman D.R., and Finucane K.E. Ventilatory responses to inspiratory threshold loading and role of muscle fatigue in task failure. J Appl Physiol 76 (1994) 185-195
26. Holmberg E., Jeppsson A.B., and Waldeck B. Selective development of tolerance to beta-adrenoceptor agonists in skeletal muscle as compared with airway smooth muscle from the guinea pig. Clin Exp Pharmacol Physiol 8 (1981) 49-56
27. Casanova C., Cote C.G., Marin J.M., et al. The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J 29 (2007) 535-540